Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
Inv. presentation
|
|
Sorrento Therapeutics, Inc. (SRNE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
4
| Sorrento Therapeutics, Inc. (10% Owner) has filed a Form 4 on Celularity Inc|
Txns:
| Sold 9,064,539 shares
@ $0
Sold 6,307,158 shares
@ $0 |
|
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2023 |
4
| Sorrento Therapeutics, Inc. (10% Owner) has filed a Form 4 on Scilex Holding Co|
Txns:
| Disposed of 73,740,795 shares
@ $0 |
|
| 12/23/2022 |
4
| Ji Henry (See Remarks) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Exercised (in-or-at-the-money) 2 options to buy
@ $5.5, valued at
$11
Exercised (in-or-at-the-money) 3 options to buy
@ $5.5, valued at
$16.5 |
|
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/07/2022 |
4
| Ji Henry (See Remarks) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Bought 88,888 shares
@ $2.0177, valued at
$179.3k
Bought 759 options to buy
@ $12, valued at
$9.1k
Bought 129 options to buy
@ $12, valued at
$1.5k
|
|
| 09/06/2022 |
4
| Ji Henry (See Remarks) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Bought 55,555 shares
@ $1.9599, valued at
$108.9k
|
|
| 09/02/2022 |
4
| Ji Henry (See Remarks) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 2,500,000 shares
@ $0 |
|
| 08/26/2022 |
4
| Ji Henry (See Remarks) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Bought 33,333 shares
@ $2.11, valued at
$70.3k
Sold 200 options to buy
@ $5.5, valued at
$1.1k
|
|
| 08/25/2022 |
4
| Ji Henry (See Remarks) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Bought 22,222 shares
@ $2.0596, valued at
$45.8k
Bought 1,000 options to buy
@ $15, valued at
$15k
|
|
| 06/14/2022 |
4
| Ji Henry (See Remarks) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $1.3999, valued at
$14k
|
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Reilly Tammy (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.51, valued at
$151k
|
|
| 12/27/2021 |
4
| Janda Kim (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Sold 3,000 shares
@ $5.88, valued at
$17.6k
Exercised 3,000 options to buy
@ $4, valued at
$12k
|
|
| 11/18/2021 |
4
| CZEREPAK ELIZABETH (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $6.01, valued at
$601k
|
|
| 09/29/2021 |
4
| Ji Henry (See Remarks) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $4, valued at
$40k
|
|
| 09/28/2021 |
4
| Janda Kim (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Sold 42,357 shares
@ $8.0204, valued at
$339.7k
Exercised 35,000 options
@ $1.8, valued at
$63k
Exercised 7,357 options
@ $3.57, valued at
$26.3k
|
|
| 09/14/2021 |
4
| Janda Kim (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Sold 8,000 shares
@ $8.0356, valued at
$64.3k
Exercised 8,000 options to buy
@ $3.5, valued at
$28k
|
|
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2021 |
4
| Ji Henry (See Remarks) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 2,500,000 options to buy
@ $8.86, valued at
$22.2M
|
|
| 08/30/2021 |
4
| Wu Yue Alexander (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $8.86, valued at
$2.2M
|
|
| 08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2021 |
4
| Lemus David (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $8.86, valued at
$2.2M
|
|
| 08/30/2021 |
4
| Janda Kim (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $8.86, valued at
$2.2M
|
|
| 08/30/2021 |
4
| Followwill Dorman (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $8.86, valued at
$2.2M
|
|
| 04/15/2021 |
4
| Janda Kim (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Sold 1,900 shares
@ $6.9742, valued at
$13.3k
Exercised 1,900 options to buy
@ $3.5, valued at
$6.7k
|
|
| 03/17/2021 |
4
| Asghar Najjam (CFO) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 56,974 shares
@ $0
Granted 100,000 options
@ $10.18, valued at
$1M
|
|
| 01/26/2021 |
4
| Followwill Dorman (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Acquired (by will) 1,000 shares
@ $0
Sold 1,000 shares
@ $7.135, valued at
$7.1k
|
|
|
|
|